CDK9-IN-8
Product Specifications
UNSPSC Description
CDK9-IN-8 is a highly effective and selective CDK9 inhibitor with an IC50 of 12 nM.
Target Antigen
CDK
Type
Reference compound
Related Pathways
Cell Cycle/DNA Damage
Applications
Cancer-Kinase/protease
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/CDK9-IN-8.html
Purity
99.65
Solubility
DMSO : 5.2 mg/mL (ultrasonic;warming;heat to 80°C)|H2O : < 0.1 mg/mL (ultrasonic;warming;heat to 80°C)
Smiles
FC1=CC=C(NC(C2(CC2)C(NC3=CC=C(NC4=NC=C5C(N(C6CCCC6)C(C(N(C)C)=O)=C5)=N4)C=C3)=O)=O)C=C1
Molecular Weight
569.63
References & Citations
[1]Li Y, et al. Discovery of a highly potent, selective and novel CDK9 inhibitor as an anticancer drug candidate. Bioorg Med Chem Lett. 2017 Aug 1;27(15):3231-3237.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Product Datasheet
http://file.medchemexpress.com/batch_PDF/HY-102039/CDK9-IN-8-DataSheet-MedChemExpress.pdf
Product MSDS
http://file.medchemexpress.com/batch_PDF/HY-102039/CDK9-IN-8-SDS-MedChemExpress.pdf
Clinical Information
No Development Reported
CAS Number
2105956-51-0
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
![[4-Phenyl-5-(2-p-tolyl-quinolin-4-yl)-4H-[1,2,4]triazol-3-ylsulfanyl]-acetic acid](https://cdn.genprice.uk/genprice/genprice3.png)
sc-349707A 1 g
[4-Phenyl-5-(2-p-tolyl-quinolin-4-yl)-4H-[1,2,4]triazol-3-ylsulfanyl]-acetic acid
Ask
View Details 
36104121 3 x 1.0μg DNA
PCDH11X CRISPRa sgRNA lentivector (set of three targets)(Human)
Ask
View Details